SLP - Simulations Plus, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Lancaster,
United States
Type: Equity
SLP price evolution
SLP
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $37.03 | $39.79 | $57.52 | |
| Short term investments | $71.47 | $74.1 | $57.94 | |
| Net receivables | $13.11 | $10.35 | $10.2 | |
| Inventory | ||||
| Total current assets | $127.96 | $129.69 | $130.37 | |
| Long term investments | $9.02 | |||
| Property, plant & equipment | $1.91 | $1.6 | $1.92 | |
| Goodwill & intangible assets | $52.24 | $52.23 | $51.95 | |
| Total noncurrent assets | $66.02 | $56.09 | $55.73 | |
| Total investments | $80.5 | $74.1 | $57.94 | |
| Total assets | $193.97 | $185.78 | $186.1 | |
| Current liabilities | ||||
| Accounts payable | $5.47 | $2.61 | $3.39 | |
| Deferred revenue | $2.46 | $2.66 | $3.1 | |
| Short long term debt | $0.42 | $0.42 | $0.44 | |
| Total current liabilities | $14.53 | $8.59 | $11.99 | |
| Long term debt | $0.61 | $0.67 | $0.76 | |
| Total noncurrent liabilities | $2.41 | $4.85 | $4.08 | |
| Total debt | $1.03 | $1.09 | $1.2 | |
| Total liabilities | $16.93 | $13.44 | $16.07 | |
| Shareholders' equity | ||||
| Retained earnings | $28.78 | $25.95 | $25.2 | |
| Other shareholder equity | -$0.21 | -$0.2 | -$0.14 | |
| Total shareholder equity | $177.04 | $172.34 | $170.03 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $57.52 | $51.57 | $36.98 | $49.21 |
| Short term investments | $57.94 | $76.67 | $86.62 | $66.8 |
| Net receivables | $10.2 | $13.79 | $13 | $10.52 |
| Inventory | ||||
| Total current assets | $130.37 | $146.79 | $139.31 | $129.09 |
| Long term investments | ||||
| Property, plant & equipment | $1.92 | $2.05 | $3.11 | $1.36 |
| Goodwill & intangible assets | $51.95 | $39.1 | $37.5 | $37.91 |
| Total noncurrent assets | $55.73 | $41.59 | $40.66 | $39.33 |
| Total investments | $57.94 | $76.67 | $86.62 | $66.8 |
| Total assets | $186.1 | $188.38 | $179.98 | $168.42 |
| Current liabilities | ||||
| Accounts payable | $3.39 | $0.23 | $0.39 | $6.41 |
| Deferred revenue | $3.1 | $2.86 | $0.65 | $0.44 |
| Short long term debt | $0.44 | $0.46 | $0.38 | $0.46 |
| Total current liabilities | $11.99 | $7.74 | $11.57 | $5.5 |
| Long term debt | $0.76 | $0.94 | $0.9 | $0.46 |
| Total noncurrent liabilities | $4.08 | $2.4 | $2.62 | $6.88 |
| Total debt | $1.2 | $1.4 | $1.28 | $0.93 |
| Total liabilities | $16.07 | $10.13 | $14.2 | $12.39 |
| Shareholders' equity | ||||
| Retained earnings | $25.2 | $40.04 | $32.41 | $27.44 |
| Other shareholder equity | -$0.14 | -$0.31 | -$0.04 | $0.06 |
| Total shareholder equity | $170.03 | $178.25 | $165.78 | $156.04 |
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $18.3 | |||
| Cost of revenue | $5.08 | |||
| Gross Profit | $13.22 | |||
| Operating activities | ||||
| Research & development | $1.31 | |||
| Selling, general & administrative | $7.47 | |||
| Total operating expenses | $8.78 | |||
| Operating income | $4.44 | |||
| Income from continuing operations | ||||
| EBIT | $5.25 | |||
| Income tax expense | $1.22 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | $4.03 | |||
| Income (for common shares) | $4.03 | |||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $59.58 | $53.91 | $46.47 | $41.59 |
| Cost of revenue | $11.63 | $10.82 | $10.6 | $10.65 |
| Gross Profit | $47.95 | $43.08 | $35.87 | $30.94 |
| Operating activities | ||||
| Research & development | $4.5 | $3.21 | $4.05 | $2.97 |
| Selling, general & administrative | $34.72 | $24.96 | $20.57 | $16.36 |
| Total operating expenses | $39.22 | $28.17 | $24.61 | $19.33 |
| Operating income | $8.72 | $14.91 | $11.25 | $11.61 |
| Income from continuing operations | ||||
| EBIT | $11.7 | $15.12 | $11.11 | $11.39 |
| Income tax expense | $1.73 | $2.63 | $1.3 | $2.05 |
| Interest expense | $0.02 | |||
| Net income | ||||
| Net income | $9.96 | $12.48 | $9.78 | $9.33 |
| Income (for common shares) | $9.96 | $12.48 | $9.78 | $9.33 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $4.03 | $1.95 | $0.53 | $4.01 |
| Operating activities | ||||
| Depreciation | $1.1 | $1.09 | $1.04 | $0.94 |
| Business acquisitions & disposals | -$8.22 | |||
| Stock-based compensation | $1.78 | $1.36 | $1.28 | $1.25 |
| Total cash flows from operations | $5.81 | $0.16 | $3.06 | $8.55 |
| Investing activities | ||||
| Capital expenditures | -$1.3 | -$0.85 | -$0.86 | -$0.82 |
| Investments | -$6 | -$15.77 | $9.69 | $9.18 |
| Total cash flows from investing | -$7.52 | -$16.86 | $0.52 | $7.92 |
| Financing activities | ||||
| Dividends paid | -$1.2 | -$1.2 | -$1.2 | -$1.2 |
| Sale and purchase of stock | $0.15 | $0.16 | $0.01 | $0.57 |
| Net borrowings | ||||
| Total cash flows from financing | -$1.05 | -$1.03 | -$1.19 | -$0.63 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.76 | -$17.73 | $2.39 | $15.84 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $9.96 | $12.48 | $9.78 | $9.33 |
| Operating activities | ||||
| Depreciation | $3.84 | $3.57 | $3.59 | $2.96 |
| Business acquisitions & disposals | -$8.22 | -$5.67 | ||
| Stock-based compensation | $4.83 | $3.04 | $2.75 | $1.58 |
| Total cash flows from operations | $21.86 | $17.9 | $19.2 | $10.91 |
| Investing activities | ||||
| Capital expenditures | -$3.67 | -$3.97 | -$4.58 | -$2.58 |
| Investments | $19.86 | $8.28 | -$22.17 | -$67.25 |
| Total cash flows from investing | $7.37 | $4.3 | -$26.74 | -$75.51 |
| Financing activities | ||||
| Dividends paid | -$4.81 | -$4.85 | -$4.81 | -$4.25 |
| Sale and purchase of stock | -$18.46 | $0.89 | $1.46 | $108.38 |
| Net borrowings | -$3.67 | -$1.33 | -$1.76 | |
| Total cash flows from financing | -$23.27 | -$7.62 | -$4.68 | $102.37 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $5.96 | $14.58 | -$12.22 | $37.77 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.09 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |